Moreover, targeted inhibition of PTGDS could decrease the expression of CDK4, an essential factor in the transformation from G1 phase to S phase, and significantly increase the expression of CDK inhibitors P21 and P27 in PTCL cells (Fig. 2j). The gene discussed is CDK4; the disease is mature T-cell and NK-cell non-Hodgkin lymphoma.